{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:13:12Z","timestamp":1790867592480,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T00:00:00Z","timestamp":1557446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1079-4","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T07:03:17Z","timestamp":1557471797000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Evaluation of the frequency of non-motor symptoms of Parkinson\u2019s disease in adult patients with Gaucher disease type 1"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8302-7705","authenticated-orcid":false,"given":"Matheus V. M. B.","family":"Wilke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al\u00edcia D.","family":"Dornelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur S.","family":"Schuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo P.","family":"Vairo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suelen P.","family":"Basgalupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiele","family":"Nalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otavio B.","family":"Piltcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida V. D.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,10]]},"reference":[{"key":"1079_CR1","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jneuroim.2014.11.005","volume":"278","author":"F Vairo","year":"2015","unstructured":"Vairo F, Sperb-Ludwig F, Wilke M, Michellin-Tirelli K, Netto C, Neto EC, et al. Brain-derived neurotrophic factor expression increases after enzyme replacement therapy in Gaucher disease. J Neuroimmunol. 2015;278:190\u20133. \n                    https:\/\/doi.org\/10.1016\/j.jneuroim.2014.11.005\n                    \n                  .","journal-title":"J Neuroimmunol"},{"issue":"2","key":"1079_CR2","doi-asserted-by":"publisher","first-page":"E441","DOI":"10.3390\/ijms18020441","volume":"18","author":"J Stirnemann","year":"2017","unstructured":"Stirnemann J, Belmatoug N, Camou F, Serratrice C, Froissart R, Caillaud C, et al. A review of gaucher disease pathophysiology, clinical presentation and treatments. Int J Mol Sci. 2017;18(2):E441. \n                    https:\/\/doi.org\/10.3390\/ijms18020441\n                    \n                  .","journal-title":"Int J Mol Sci"},{"key":"1079_CR3","unstructured":"Pastores GM, Hughes DA. Gaucher Disease. 2000 Jul 27 [Updated 2018 Jun 21]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132018."},{"key":"1079_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/jnc.13385","volume":"139 Suppl 1","author":"A Migdalska-Richards","year":"2016","unstructured":"Migdalska-Richards A, Schapira AH. The relationship between glucocerebrosidase mutations and parkinson disease. J Neurochem. 2016;139 Suppl 1:77\u201390.","journal-title":"J Neurochem"},{"issue":"6","key":"1079_CR5","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s10571-018-0587-4","volume":"38","author":"A Karimi-Moghadam","year":"2018","unstructured":"Karimi-Moghadam A, Charsouei S, Bell B, Jabalameli MR. Parkinson disease from mendelian forms to genetic susceptibility: new molecular insights into the neurodegeneration process. Cell Mol Neurobiol. 2018;38(6):1153\u201378. \n                    https:\/\/doi.org\/10.1007\/s10571-018-0587-4\n                    \n                  .","journal-title":"Cell Mol Neurobiol"},{"issue":"4","key":"1079_CR6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.7861\/clinmedicine.16-4-365","volume":"16","author":"A Sauerbier","year":"2016","unstructured":"Sauerbier A, Qamar MA, Rajah T, Chaudhuri KR. New concepts in the pathogenesis and presentation of Parkinson\u2019s disease. Clin Med Lond. 2016;16(4):365\u201370. \n                    https:\/\/doi.org\/10.7861\/clinmedicine.16-4-365\n                    \n                  .","journal-title":"Clin Med Lond"},{"issue":"1\u20132","key":"1079_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000447510","volume":"76","author":"EM Gatto","year":"2016","unstructured":"Gatto EM, Etcheverry JL, Sanguinetti A, Cesarini M, Fernandez Escobar N, Drelichman G. Prodromal clinical markers of Parkinson disease in Gaucher disease individuals. Eur Neurol. 2016;76(1\u20132):19\u201321. \n                    https:\/\/doi.org\/10.1159\/000447510\n                    \n                  .","journal-title":"Eur Neurol"},{"issue":"4","key":"1079_CR8","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/mds.24945","volume":"27","author":"A McNeill","year":"2012","unstructured":"McNeill A, Duran R, Proukakis C, Bras J, Hughes D, Mehta A, et al. Hyposmia and cognitive impairment in Gaucher disease patients and carriers. Mov Disord. 2012;27(4):526\u201332.","journal-title":"Mov Disord"},{"issue":"2","key":"1079_CR9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.beem.2014.08.007","volume":"29","author":"D Elstein","year":"2015","unstructured":"Elstein D, Alcalay R, Zimran A. The emergence of Parkinson disease among patients with Gaucher disease. Best Pract Res Clin Endocrinol Metab. 2015;29(2):249\u201359. \n                    https:\/\/doi.org\/10.1016\/j.beem.2014.08.007\n                    \n                  .","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"Pt A","key":"1079_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mcn.2015.03.013","volume":"66","author":"AH Schapira","year":"2015","unstructured":"Schapira AH. Glucocerebrosidase and Parkinson disease: recent advances. Mol Cell Neurosci. 2015;66(Pt A):37\u201342. \n                    https:\/\/doi.org\/10.1016\/j.mcn.2015.03.013\n                    \n                  .","journal-title":"Mol Cell Neurosci"},{"issue":"2","key":"1079_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1001\/jamaneurol.2014.2950","volume":"72","author":"M Beavan","year":"2015","unstructured":"Beavan M, McNeill A, Proukakis C, Hughes DA, Mehta A, Schapira AH. Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort. JAMA Neurol. 2015;72(2):201\u20138.","journal-title":"JAMA Neurol"},{"issue":"9","key":"1079_CR12","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1212\/WNL.0000000000001315","volume":"84","author":"Z Gan-Or","year":"2015","unstructured":"Gan-Or Z, Amshalom I, Kilarski LL, Bar-Shira A, Gana-Weisz M, Mirelman A, et al. Differential effects of severe vs mild GBA mutations on parkinson disease. Neurology. 2015;84(9):880\u20137. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000001315\n                    \n                  .","journal-title":"Neurology"},{"key":"1079_CR13","unstructured":"Schulte C, Liepelt-Scarfone I, Hagen CE, Hauser AK, Brockmann K, et al. Coding and non-coding glucocerebrosidase variants have an impact on cognitive decline in Parkinson\u2019s disease [abstract]. Mov Disord. 2016;31(suppl 2). \n                    https:\/\/www.mdsabstracts.org\/abstract\/coding-and-non-coding-glucocerebrosidase-variants-have-an-impact-on-cognitive-decline-in-parkinsons-disease\n                    \n                  ."},{"issue":"8","key":"1079_CR14","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s00415-018-8908-6","volume":"265","author":"LM Collins","year":"2018","unstructured":"Collins LM, Williams-Gray CH, Morris E, Deegan P, Cox TM, Barker RA. The motor and cognitive features of Parkinson\u2019s disease in patients with concurrent Gaucher disease over 2 years: a case series. J Neurol. 2018;265(8):1789\u201394. \n                    https:\/\/doi.org\/10.1007\/s00415-018-8908-6\n                    \n                  .","journal-title":"J Neurol"},{"issue":"4","key":"1079_CR15","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1017\/S1041610211002511","volume":"24","author":"E Moore","year":"2012","unstructured":"Moore E, Mander A, Ames D, Carne R, Sanders K, Watters D. Cognitive impairment and vitamin B12: a review. Int Psychogeriatr. 2012;24(4):541\u201356. \n                    https:\/\/doi.org\/10.1017\/S1041610211002511\n                    \n                  .","journal-title":"Int Psychogeriatr"},{"issue":"2","key":"1079_CR16","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1212\/NXG.0000000000000057","volume":"2","author":"G Lopez","year":"2016","unstructured":"Lopez G, Kim J, Wiggs E, Cintron D, Groden C, Tayebi N, et al. Clinical course and prognosis in patients with Gaucher disease and parkinsonism. Neurol Genet. 2016;2(2):e57. \n                    https:\/\/doi.org\/10.1212\/NXG.0000000000000057\n                    \n                  .","journal-title":"Neurol Genet"},{"key":"1079_CR17","unstructured":"Thaler A, Bregman N, Gurevich T, Shiner T, Dror Y, Zmira O, et al. Parkinson\u2019s disease phenotype is influenced by the severity of the mutations in the GBA gene. Parkinsonism Relat Disord. 2018. S1353-8020(18)30239-6."},{"issue":"6","key":"1079_CR18","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s10545-012-9460-7","volume":"35","author":"M Biegstraaten","year":"2012","unstructured":"Biegstraaten M, Wesnes KA, Luzy C, Petakov M, Mrsic M, Niederau C, et al. The cognitive profile of type 1 gaucher disease patients. J Inherit Metab Dis. 2012;35(6):1093\u20139. \n                    https:\/\/doi.org\/10.1007\/s10545-012-9460-7\n                    \n                  .","journal-title":"J Inherit Metab Dis"},{"issue":"7","key":"1079_CR19","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/mds.25037","volume":"27","author":"RB Postuma","year":"2012","unstructured":"Postuma RB, Arnulf I, Hogl B, Iranzo A, Miyamoto T, et al. A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation study. Mov Disord. 2012;27(7):913\u20136.","journal-title":"Mov Disord"},{"issue":"6","key":"1079_CR20","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/mds.26989","volume":"32","author":"SM Fereshtehnejad","year":"2017","unstructured":"Fereshtehnejad SM, Montplaisir JY, Pelletier A, Gagnon JF, Berg D, Postuma RB. Validation of the MDS research criteria for prodromal Parkinson\u2019s disease: longitudinal assessment in a REM sleep behavior disorder (RBD) cohort. Mov Disord. 2017;32(6):865\u201373.","journal-title":"Mov Disord"},{"key":"1079_CR21","doi-asserted-by":"publisher","unstructured":"Choi JM, Kim WC, Lyoo CH, Kang SY, Lee PH, Baik JS, et al. Association of mutations in the glucocerebrosidase gene with parkinson disease in a korean population. 2012. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2012.02.035\n                    \n                  .","DOI":"10.1016\/j.neulet.2012.02.035"},{"key":"1079_CR22","doi-asserted-by":"publisher","unstructured":"Horowitz M, Pasmanik-Chor M, Ron I, Kolodny EH. The enigma of the E326K mutation in acid \u03b2- glucocerebrosidase. 2011. \n                    https:\/\/doi.org\/10.1016\/j.ymgme.2011.07.002\n                    \n                  .","DOI":"10.1016\/j.ymgme.2011.07.002"},{"issue":"3","key":"1079_CR23","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s10897-017-0161-0","volume":"27","author":"M Mulhern","year":"2018","unstructured":"Mulhern M, Bier L, Alcalay RN, Balwani M. Patients\u2019 opinions on genetic counseling on the increased risk of Parkinson disease among Gaucher disease carriers. J Genet Couns. 2018;27(3):675\u201380. \n                    https:\/\/doi.org\/10.1007\/s10897-017-0161-0\n                    \n                  .","journal-title":"J Genet Couns"},{"key":"1079_CR24","doi-asserted-by":"crossref","unstructured":"Rees RN, Acharya AP, Schrag A, Noyce AJ. An early diagnosis is not the same as a timely diagnosis of parkinson\u2019s disease. eCollection 2018. Faculty Rev. 2018:1106.","DOI":"10.12688\/f1000research.14528.1"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1079-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1079-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1079-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:15:57Z","timestamp":1588965357000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1079-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,10]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1079"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1079-4","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,10]]},"assertion":[{"value":"10 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethics committee of Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil under the number:78018217800005327. All participants were asked to sign an informed consent form for participation in the study and publication of data. The signed consent forms can be retrieved from the Genetics Department of Hospital de Clinicas de Porto Alegre, Brazil, if needed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"103"}}